Navigation Links
AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
Date:5/15/2013

bVie Oncology

The fight against cancer is one of the greatest battles in medicine and the varied nature of the disease requires a diverse approach that looks at multiple disease targets in a variety of tumor types. AbbVie's oncology research is focused on the discovery and development of targeted therapies that work against the processes cancers need to survive. By investing in new technologies and approaches, we are breaking ground in some of the most widespread and difficult-to-treat cancers, including multiple myeloma and chronic lymphocytic leukemia. Our oncology pipeline includes multiple new molecules in clinical trials being studied in more than 15 different cancers and tumor types.

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.


'/>"/>
SOURCE AbbVie
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
2. AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care Conference
3. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
4. AbbVie CF Scholarship Application Now Available for Exceptional Undergraduate and Graduate Students with Cystic Fibrosis
5. AbbVie Reports First-Quarter 2013 Financial Results
6. AbbVie to Host First-Quarter Earnings Conference Call
7. Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
8. AbbVie to Present at Barclays Global Health Care Conference
9. AbbVie Issues Inaugural Full-Year Outlook for 2013
10. AbbVie Named to S&P 500 Dividend Aristocrat Index
11. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... ST. PAUL, Minn. , Sept. 30, 2014 /PRNewswire/ ... the United States abused prescription pain ... dependence include detoxification or maintenance treatment, which entails the ... and costs of these treatments are important when developing ... studies by pharmacy benefit manager Prime Therapeutics ...
(Date:9/30/2014)... SAN DIEGO , Sept. 30, 2014 /PRNewswire/ ... a three-dimensional biology company focused on delivering breakthrough ... Human Liver Model has been selected as a finalist ... the 2014 Most Innovative New Product Awards, sponsored ... creation of innovative technology and life sciences products ...
(Date:9/30/2014)... -- , A series of Health ... change the way retail pharmaceutical companies are perceived   ... and view pharmacies, Health First Pharmacy is redefining the ... very trendy public demands of customisation and accessibility, the ... various activities for both children and adults starting from ...
Breaking Medicine Technology:Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3Health First Pharmacy Redefines 'Pharmacy Retail Experience' 2Health First Pharmacy Redefines 'Pharmacy Retail Experience' 3
... , , NEW YORK , ... Jay Hoffman , PhD, professor and chair of the Department of ... , has shown Sustamine™ L-Alanyl-L-Glutamine, increases performance in endurance exercise and ... in the Journal of the International Society of Sports Nutrition ...
... , SEATTLE , Feb. 11 ... today announced record 2009 sales results. The successful launch of ... in excess of 75% and the company,s first cash flow ... the company,s manufacturing capacity for 2009 and well into 2010. ...
Cached Medicine Technology:Clinical Study Shows Sustamine(TM) L-Alanyl-L-Glutamine Increases Performance in Endurance, Exercise and Activity 2Clinical Study Shows Sustamine(TM) L-Alanyl-L-Glutamine Increases Performance in Endurance, Exercise and Activity 3Clinical Study Shows Sustamine(TM) L-Alanyl-L-Glutamine Increases Performance in Endurance, Exercise and Activity 4Amnis Announces Record 2009 Sales 2
(Date:9/30/2014)... (PRWEB) September 30, 2014 A group of ... to combat an epidemic that, left unchecked, could create a ... are not headed to Africa. John Rogers, the Executive Director ... North Korea to fight a disease most think mankind conquered ... some 80 years ago is on the comeback in several ...
(Date:9/30/2014)... 2014 Bifidobacteria, the primary bacteria found ... diet, and stress, so a high Bifido probiotic can ... Ultimate Flora™ Men’s Complete contains 90 Billion ... Bifidobacteria strains to support a healthy large intestine (colon) ... and 32 billion cultures from 7 Lactobacillus strains to ...
(Date:9/30/2014)... in reducing the stigma associated with seeking help for ... but more improvement is still needed, according to a ... the Defense Department and the Veterans Health Administration to ... not seek needed care for mental health problems. ... treatment as a way to reduce stigma, according to ...
(Date:9/30/2014)... September 30, 2014 Healthcare advocates, patient ... National Association of Health Advocacy Consultants (#NAHAC) fifth annual ... (#NAHAC14) to be held October 30th - Nov. 1st, ... at NAHAC14: Standards and Best Practices for the Field ... a profession, advocates have needed a set of standards ...
(Date:9/30/2014)... Healthpointe is proud to announce that ... and ankle reconstruction surgeries to assist patients with severe ... specializes in the diagnosis and treatment of sports medicine, ... also trained to perform advanced Foot and Ankle Reconstruction ... is also fluent in Spanish. , Reconstructive surgical procedures ...
Breaking Medicine News(10 mins):Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2Health News:ReNew Life Introduces Ultimate Flora™ Men’s Complete Probiotic 90 Billion—Comprehensive Probiotic Support Just for Men 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 3Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 2Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 3
... a leader,in the development and marketing of disposable ... announced today that,BSSI has been purchased by Linden ... to Microflex(R), BSSI also owns MicroActive Corporation and,FoodHandler(R), ... leading supplier,of health and safety barrier products to ...
... and special initiatives encourage smokers to say ,I Quit, at The ... ... There,s some,ash-kicking, going on at the BODY WORLDS exhibit. Lung Cancer ... California,s,6-session Ash Kickers Quit Smoking Class and BODY WORLDS, I Quit ...
... Americans Have No Long Term Care Plans, WASHINGTON, ... long term care has on American families, the U.S. ... resolution proclaiming its,support for national Long Term Care Awareness ... one of the nation,s leading providers of,individual long term ...
... raising goal for United Way of ... ... Company,(NYSE: LLY ) chairman and chief executive officer Sidney Taurel ... Lilly,s,commitment to the agency,s 2008 fundraising campaign. For the United Way ...
... researchers find , TUESDAY, Nov. 6 (HealthDay News) -- ... of preclinical cardiovascular disease, U.S researchers report.. , Researchers ... women (who were free of cardiovascular disease at the ... intima media thickness (cIMT), a measure of the ...
... a mother with Alzheimers disease appear to be at higher risk ... according to a new study by NYU School of Medicine researchers. ... in this weeks online edition of the Proceedings of the National ... among cognitively normal people who have a father, a mother, or ...
Cached Medicine News:Health News:Microflex(R) Corporation Acquired by Linden and Edgewater 2Health News:BODY WORLDS 2 & Breathe California Pair Up for Some 'Ash Kicking' 2Health News:BODY WORLDS 2 & Breathe California Pair Up for Some 'Ash Kicking' 3Health News:Congress Proclaims Support for Long Term Care Awareness Week; Recent Poll Shows Voters Want Long Term Care Included in Presidential Candidates' Healthcare Proposals 2Health News:Congress Proclaims Support for Long Term Care Awareness Week; Recent Poll Shows Voters Want Long Term Care Included in Presidential Candidates' Healthcare Proposals 3Health News:Lilly Contributes $10.8 Million to United Way Annual Campaign 2Health News:A maternal link to Alzheimer's disease 2Health News:A maternal link to Alzheimer's disease 3
For the quantitative in vitro determination of Alanine Aminotransferase (ALT) in serum and plasma....
For the quantitative in vitro determination of Alkaline Phosphatase in serum or plasma....
... Tm Bioscience introduces the Tag-It™ Cystic Fibrosis ... cystic fibrosis genotyping. With validated performance criteria, ... will provide superior mutation coverage for carrier ... to diagnosis in newborns. ,The Tag-It™ ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: